Mark J. Liang, M.D.

Mark J. Liang, M.D.
Place of Birth

Rome, Georgia


Marital Status

Married, three children


Education  
9/75 - 8/76

Floyd Junior College
Joint Enrollment Program
Rome, Georgia 30161

9/76 - 8/78

University of Georgia
Athens, Georgia 30602
Degree: B.S. Chemistry

Honors

Honorary Freshman
Academic Achievement Society
Alpha Epsilon Delta
Premedical Honor Society
Magna Cum Laude

9/78 - 6/82

Medical College of Georgia
Augusta, Georgia 30901
Degree: M.D.


Residency/Internship  
7/82 - 6/86

Bowman Gray School of Medicine
North Carolina Baptist Hospital
Winston Salem, NC
Resident: Radiation Oncology
Chief Resident (1986)

7/85 - 6/86

Chief Resident (1986)


Employment  
1986 - 1987

Bowman Gray School of Medicine (Instructor)
Department of Radiation Therapy
Winston Salem, NC

1987 - Present

Southeast Radiation Oncology Group, P.A.
200 Queens Road, Suite 400, Charlotte, NC 28204.


Practice Location

Matthews Radiation Oncology Center
1400 Matthews Township Parkway
Matthews, NC 28105
Telephone: 704-845-8800

University Radiation Oncology


Board Certified

The American Board of Radiology, June 6, 1986 (Therapeutic Radiology)
Diplomat National Board of Medical Examiners


Licensure

North Carolina, January 21, 1984
South Carolina, September 19, 1988


Professional Activities

American Medical Association
American Society of Therapeutic Radiology and Oncology
American College of Radiology


Abstracts

Richard F II, Atkins JN, Scarantion C, Sterchi JM, Liang MJ, Muss HB, Sekan P, Case D: Phase I study of intraperitoneal 5-fluorouracil (IP-5FU) with local radiation therapy (RT) as adjuvant therapy in State B3 and C1, 2, 3 colon cancer. Proc. ASCO 1986; 5:80


Research

Londiamin - Radiation Therapy in the initial treatment of clinically localized but nonrespectable epidermoid cancer of the lung.

Principle Investigator, Author of Radiotherapy Section, and Liason with National Cancer Institute, Bowman Gray Protocol #54284, Intraperitoneal 5-Fluorouracil with Local Radiation Therapy as Adjuvant Therapy in Stages B3 and C1, 2, 3 Colon Cancer. A pilot study: Phase I.

Co-Investigator, STents And Radiation Therapy (START) Trial. (Novoste)

Co-Investigator, The Beta-Cath System Trial. A Prospective, Randomized, Placebo-controlled, Triple-masked Trial to Evaluate the Safety and Effectiveness of the Novoste Beta-Cath System in Native Coronary Arteries. (Novoste/CDAC) (N=80)


Publications

McCunniff, Ann J., M.D.; Liang Mark J., M.D. "Radiation Tolerance of the Cervical Spinal Cord." International Journal of Radiation Oncology,Volume 16, Number 3, pg. 675-678.


Hospital Committees/Task Groups  
1987 - 1989

Physician Member of the Development and Design Team for Gaston Memorial Hospital Radiation Oncology Department.

1995 - 1996

Assisted Design Team for Radiation Oncology Department at Presbyterian Hospital and Matthews Radiation Oncology.

1994 - 1996

Presbyterian Pain Task Force

1995 - present

Gastrointestinal Tumor Committee at Presbyterian Hospital

1995 - 1996

Presbyterian Computer/Information Task Force

1992 - 1997

Organization Committee of Presbyterian Hospital Yearly Cancer Symposium


Other  
1986 - 1987

Co-Quality Control Officer for POA Protocol #62486. A double-blind, prospectively randomized trial comparing the efficacy of combined placebo - Radiation Therapy versus Londiamin - Radiation Therapy in the initial treatment of clinically localized but nonrespectable epidermoid cancer of the lung.

1997 -

Co-Investigator at Presbyterian Hospital for Novoste Beta-Cath trial.

Past

Secretary, Southeast Radiation Oncology Group, P.A.

Current

Secretary/Treasurer, Matthews Radiation Oncology, Inc.

Past/Present

Responsibility for Scheduling Physician Manpower For ten Practice Locations/twenty-one Physicians. (1989 - Present)

CARROS North Carolina president and CARROS representative to NC-ACR (1999).